HomeESLA • NASDAQ
add
Estrella Immunopharma Inc
Previous close
$1.05
Day range
$1.01 - $1.06
Year range
$0.73 - $3.15
Market cap
43.95M USD
Avg Volume
53.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Business Wire
14 minutes ago
Backblaze Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2.50%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 613.20K | -41.61% |
Net income | -613.17K | 41.62% |
Net profit margin | — | — |
Earnings per share | -0.01 | — |
EBITDA | — | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.38M | -66.77% |
Total assets | 3.18M | -28.67% |
Total liabilities | 13.54M | 351.88% |
Total equity | -10.37M | — |
Shares outstanding | 42.67M | — |
Price to book | -3.89 | — |
Return on assets | -45.76% | — |
Return on capital | 15.18% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -613.17K | 41.62% |
Cash from operations | -177.49K | 80.19% |
Cash from investing | — | — |
Cash from financing | -64.82K | -518.77% |
Net change in cash | -242.31K | 56.87% |
Free cash flow | 50.44K | -95.77% |
About
Founded
2006
Headquarters
Website
